EGFR amplification status for clinical trial inclusion: where do we draw the line? (Record no. 30096114)

MARC details
000 -LEADER
fixed length control field 00825 a2200229 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518060749.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202002s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1523-5866
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1093/neuonc/noz146
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Molinaro, Annette M
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200206
245 00 - TITLE STATEMENT
Title EGFR amplification status for clinical trial inclusion: where do we draw the line?
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Neuro-oncology
Date of publication, distribution, etc. 10 2019
300 ## - PHYSICAL DESCRIPTION
Extent 1215-1216 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Comment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element ErbB Receptors
General subdivision genetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Gene Amplification
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Phillips, Joanna J
773 0# - HOST ITEM ENTRY
Title Neuro-oncology
Related parts vol. 21
-- no. 10
-- p. 1215-1216
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1093/neuonc/noz146">https://doi.org/10.1093/neuonc/noz146</a>
Public note Available from publisher's website

No items available.